RWE and HTA – a snapshot of recent developments with Sreeram Ramagopalan: December 2023–February 2024

Written by Sreeram Ramagopalan (Lane Clark & Peacock)
Artificial intelligence and machine learning Guest columns Health equity Health technology assessment Industry Updates Oncology and hematology Real-world evidence

Read highlights from the latest instalment of Sreeram Ramagopalan’s (Lane Clark & Peacock, UK) industry news round-up, which discusses some of the latest developments regarding real-world evidence (RWE) in the context of health technology assessment (HTA) and is published bi-monthly in our partner journal, the Journal of Comparative Effectiveness Research. Read the full update for December 2023–February 2024 in the Journal of Comparative Effectiveness Research here >>> What happened over these months that you were expecting? I was expecting some form of RWE guidance to arrive from the European Society for Medical Oncology (ESMO). ESMO, the leading European oncology medical society, recently...

To view this content, please register now for access

It's completely free